Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial

Clicks: 160
ID: 118288
AbstractBackground. Steroid use for COVID-19 is based on the possible role of these drugs in mitigating the inflammatory response, mainly in the lungs, trigger
Reference Key
pradoclinicalmethylprednisolone Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jeronimo, Christiane Maria Prado;Farias, Maria Eduarda Leão;Val, Fernando Fonseca Almeida;Sampaio, Vanderson Souza;Alexandre, Marcia Almeida Araújo;Melo, Gisely Cardoso;Safe, Izabella Picinin;Borba, Mayla Gabriela Silva;Abreu-Netto, Rebeca Linhares;Maciel, Alex Bezerra Silva;Neto, João Ricardo Silva;Oliveira, Lucas Barbosa;Figueiredo, Erick Frota Gomes;Dinelly, Kelry Mazurega Oliveira;Rodrigues, Maria Gabriela de Almeida;Brito, Marcelo;Mourão, Maria Paula Gomes;Pivoto João, Guilherme Augusto;Hajjar, Ludhmila Abrahão;Bassat, Quique;Romero, Gustavo Adolfo Sierra;Naveca, Felipe Gomes;Vasconcelos, Heline Lira;Tavares, Michel de Araújo;Brito-Sousa, José Diego;Costa, Fabio Trindade Maranhão;Nogueira, Maurício Lacerda;Baía-da-Silva, Djane;Xavier, Mariana Simão;Monteiro, Wuelton Marcelo;Lacerda, Marcus Vinícius Guimarães;, for the Metcovid Team;
Journal clinical infectious diseases
Year Year not found
DOI DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.